Shivani Shah, MD

Nephrology

4.8
73 Ratings
Years in Practice: 14 years
Practices In: Aurora, Winfield
Patients Seen: Adults

To pro­vide the most com­pre­hen­sive and com­pas­sion­ate care through open com­mu­ni­ca­tion, inter­dis­ci­pli­nary col­lab­o­ra­tion and clin­i­cal expertise.

Schedule an appointment with Shivani Shah, MD

A few questions to help guide us to a healthier happier you...

What's the date of birth of the patient receiving care?

Already a Duly MyChart User?
Log in for a quicker scheduling journey.

Board Certifications
Internal Medicine, Nephrology
Languages
English
Awards & Accolades
Excellence in Teaching, Clinical Instructor in Int Medicine, Dept of Medicine, Northwestern Univ. 2000
Excellence in Teaching Award, Internal Medicine Residency, Dept of Medicine, Northwestern University 2000
Alpha Omega Alpha 2000
Clinical Interests

Hyper­ten­sion, Acute Kid­ney Injury, Chron­ic Kid­ney Dis­ease, Dial­y­sis, Glomeru­lonephri­tis, Kid­ney Stones and ANCA Vasculitis

Personal Interests

Cook­ing, Spend­ing time with fam­i­ly, Traveling

Edward Hospital
801 S. Washington St. Naperville, Illinois 60540 630-527-3000 Get Directions
Northwestern Medicine Central DuPage Hospital
25 North Winfield Road Winfield, Illinois 60190 630-933-1600 Get Directions
School
Northwestern University Feinberg School of Medicine Graduation Date: 2009 Degree: MD
Residency
Northwestern University Internal Medicine
Fellowships
Johns Hopkins University Nephrology
Provider’s Publications
Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis
August 2017
Crystal-storing Histiocytosis: a Crystal Clear Diagnosis
February 2016
Relevance of ANCA positivity at the time of renal transplantation in ANCA associated vasculitis
December 2015
A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis
October 2015
Place in Therapy of Rituximab in the Treatment of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis
August 2015
Granulomatous Interstitial Nephritis
July 2015
Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab
June 2015
A Prospective Study Evaluating the Role of Donor-specific Anti-endothelial Crossmatch (XM-ONE assay) in Predicting Living Donor Kidney Transplant Outcome
November 2013

Procedures

Hemodialysis, Home Hemodialysis, Peritoneal Dialysis, Post Renal-Transplant Care, Preventive Care

Conditions

Acid/Base Abnormalities, Acute Kidney Injury, Chronic Kidney Disease, Diabetic Nephropathy, Electrolyte Disorders, End Stage Renal Disease & Dialysis, Glomerulonephritis, Hypertension, ICU Nephrology, IgA Nephropathy, Intoxications, Kidney Stones, Lupus Nephritis, Polycystic Kidney Disease, Post-renal Transplant, Vasculitis

Ratings


Ratings Category

The Patient Satisfaction Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.

Patient Satisfaction Rating

4.8
73 Ratings

Likelihood of recommending this provider

4.8
72 Ratings

Provider included you in decisions

4.8
72 Ratings

Provider showed concern

4.8
73 Ratings

Provider explained things clearly

4.8
73 Ratings

Provider discussed treatment options

4.8
72 Ratings

Comments


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.
"Dr. Shah was very thorough and took plenty of time and answered my question."
5
Dec. 28, 2023
"Dr Shah is very detailed and thorough and is a good listener. She explains things very well."
5
Dec. 10, 2023
"Always a good experience with Dr Shah. Always takes action if you have a medical problem"
5
Nov. 3, 2023
"Had me look at the monitor so that I could see the numbers that were discussed."
5
Oct. 9, 2023